Use of proton pump inhibitors and risk of hip/femur fracture: A population-based case-control study

Osteoporosis International

Volumn 22, Issue 3, 2011, Pages 903-910

  Pouwels, S ^a   Lalmohamed, A ^a   Souverein, P ^a   Cooper, C ^b,c   Veldt, B J ^d   Leufkens, H G ^a   De Boer, A ^a   Van Staa, T ^a,b,e   De Vries, F ^a,b,e  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

Author keywords

Fracture risk; Histamine H2 receptor antagonist; Proton pump inhibitor

Indexed keywords

ANTACID AGENT; ANTIRHEUMATIC AGENT; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FEMUR FRACTURE; GROUPS BY AGE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

AGED; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMORAL FRACTURES; HIP FRACTURES; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; NETHERLANDS; PROTON PUMP INHIBITORS; RISK FACTORS;

EID: 79951673896     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1337-8     Document Type: Article

References (39)

1. JE Richter 2007 Gastrooesophageal reflux disease Best Pract Res Clin Gastroenterol 21 609 631 10.1016/j.bpg.2007.03.003 17643904 (Pubitemid 47078840)
2. MB O'Connell DM Madden AM Murray, et al. 2005 Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial Am J Med 118 778 781 10.1016/j.amjmed.2005.02.007 15989913 (Pubitemid 40897665)
3. G Graziani S Badalamenti G Como, et al. 2002 Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload Nephron 91 474 479 1:CAS:528:DC%2BD38XlsFOgu78%3D 10.1159/000064290 12119480 (Pubitemid 34765248)
4. KE Ensrud T Duong JA Cauley, et al. 2000 Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Study of Osteoporotic Fractures Research Group Ann Intern Med 132 345 353 1:STN:280:DC%2BD3c7ktlSmtA%3D%3D 10691584 (Pubitemid 30127772)
5. K Mizunashi Y Furukawa K Katano, et al. 1993 Effect of omeprazole, an inhibitor of H+, K(+)-ATPase, on bone resorption in humans Calcif Tissue Int 53 21 25 1:CAS:528:DyaK3sXms1antLg%3D 10.1007/BF01352010 8102318 (Pubitemid 23187327)
6. K Rzeszutek F Sarraf JE Davies 2003 Proton pump inhibitors control osteoclastic resorption of calcium phosphate implants and stimulate increased local reparative bone growth J Craniofac Surg 14 301 307 1:STN:280: DC%2BD3s3pvFagsg%3D%3D 10.1097/00001665-200305000-00007 12826800
7. J Tuukkanen HK Väänänen 1986 Omeprazole, a specific inhibitor of H+-K+-ATPase, inhibits bone resorption in vitro Calcif Tissue Int 38 123 125 1:CAS:528:DyaL28XhsVahtrw%3D 10.1007/BF02556841 3006888 (Pubitemid 16113857)
8. YX Yang JD Lewis S Epstein, et al. 2006 Long-term proton pump inhibitor therapy and risk of hip fracture JAMA 296 2947 2953 1:CAS:528:DC%2BD2sXnvVGn 10.1001/jama.296.24.2947 17190895 (Pubitemid 46021498)
9. P Vestergaard L Rejnmark L Mosekilde 2006 Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture Calcif Tissue Int 79 76 83 1:CAS:528:DC%2BD28XosleqtL0%3D 10.1007/s00223-006-0021-7 16927047 (Pubitemid 44306164)
10. LE Targownik LM Lix CJ Metge, et al. 2008 Use of proton pump inhibitors and the risk of osteoporosis-related fractures CMAJ 179 319 326 18695179
11. F de Vries AL Cooper SM Cockle, et al. 2009 Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates Osteoporos Int 20 1989 1998 1:CAS:528:DC%2BD1MXhsVWlsrzM 10.1007/s00198-009-0891-4 19333676
12. JA Kaye H Jick 2008 Proton pump inhibitor use and risk of hip fractures in patients without major risk factors Pharmacotherapy 28 951 959 1:CAS:528:DC%2BD1cXhtVWntrfP 10.1592/phco.28.8.951 18657011
13. ER Heerdink HG Leufkens RM Herings, et al. 1998 NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics Arch Intern Med 158 1108 1112 1:STN:280:DyaK1c3ms1yiuw%3D%3D 10.1001/archinte.158.10.1108 9605782 (Pubitemid 28242315)
14. Herings R (1993) The PHARMO Drug Data Base: design and structure. PHARMO, a record linkage system for post-marketing surveillance of prescription drugs in the Netherlands. Doctoral thesis. Utrecht University, Utrecht, the Netherlands, pp 17-32
15. RM Herings BH Stricker A de Boer, et al. 1995 Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life Arch Intern Med 155 1801 1807 1:CAS:528:DyaK2MXotVOmsrY%3D 10.1001/archinte.155.16.1801 7654115
16. Norwegian Institute of Public Health. WHO International Working Group for drug statistics methodology. 2009; Available at http://www.whocc.no/atcddd/
17. TP van Staa HG Leufkens L Abenhalm, et al. 2000 Use of oral corticosteroids and risk of fractures J Bone Miner Res 15 993 1000 10.1359/jbmr.2000.15.6.993 10841167 (Pubitemid 30350061)
18. RF Laan PL van Riel LB van de Putte, et al. 1993 Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study Ann Intern Med 119 963 968 1:STN:280: DyaK2c%2FivVertg%3D%3D 8105737 (Pubitemid 23334651)
19. S Greenland 1995 Dose-response and trend analysis in epidemiology: alternatives to categorical analysis Epidemiology 6 356 365 1:STN:280: DyaK28%2FjvF2kuw%3D%3D 10.1097/00001648-199507000-00005 7548341
20. Hoogerwerf W, Pasricha P (2001) Agents used for control of gastric acidity and treatment of ulcers and gastroesophageal reflux disease. In: Goodman & Gilman's. The pharmacological basis of therapeutics. The McGraw-Hill Companies, Inc, United States of America, pp 1005-1020
21. KL Insogna 2009 The effect of proton pump-inhibiting drugs on mineral metabolism Am J Gastroenterol 104 2 Suppl S2 S4 1:CAS:528:DC%2BD1MXmsVGjtr0%3D 10.1038/ajg.2009.44 19262542
22. P Hardy A Sechet C Hottelart, et al. 1998 Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis Artif Organs 22 569 573 1:CAS:528:DyaK1cXkvVWjt7s%3D 10.1046/j.1525-1594.1998.06200.x 9684693 (Pubitemid 28324030)
23. RR Recker 1985 Calcium absorption and achlorhydria N Engl J Med 313 70 73 1:STN:280:DyaL2M3htlOrtg%3D%3D 10.1056/NEJM198507113130202 4000241 (Pubitemid 15068699)
24. C Serfaty-Lacrosniere RJ Wood D Voytko, et al. 1995 Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans J Am Coll Nutr 14 364 368 1:CAS:528:DyaK2MXnsVOms7g%3D 8568113
25. TA Knox Z Kassarjian B Dawson-Hughes, et al. 1991 Calcium absorption in elderly subjects on high- and low-fiber diets: effect of gastric acidity Am J Clin Nutr 53 1480 1486 1:STN:280:DyaK3M3ktFSmtQ%3D%3D 1852094 (Pubitemid 21898903)
26. P Ivanovich H Fellows C Rich 1967 The absorption of calcium carbonate Ann Intern Med 66 917 923 1:STN:280:DyaF2s7mtFWktA%3D%3D 6025232
27. I Kocsis A Arato H Bodanszky, et al. 2002 Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children Calcif Tissue Int 71 129 132 1:CAS:528:DC%2BD38Xms1emu78%3D 10.1007/s00223-001-2068-9 12200646 (Pubitemid 36935477)
28. EW Yu T Blackwell KE Ensrud, et al. 2008 Acid-suppressive medications and risk of bone loss and fracture in older adults Calcif Tissue Int 83 251 259 1:CAS:528:DC%2BD1cXht1Krtr7M 10.1007/s00223-008-9170-1 18813868
29. LE Targownik LM Lix S Leung, et al. 2009 Proton pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss Gastroenterology 138 896 904 10.1053/j.gastro.2009.11.014 19931262
30. RG Cumming MC Nevitt SR Cummings 1997 Epidemiology of hip fractures Epidemiol Rev 19 244 257 1:STN:280:DyaK1c7lsFyqsg%3D%3D 9494786 (Pubitemid 28099774)
31. C De Laet JA Kanis A Odén, et al. 2005 Body mass index as a predictor of fracture risk: a meta-analysis Osteoporos Int 16 1330 1338 10.1007/s00198-005-1863-y 15928804 (Pubitemid 41532085)
32. JA Kanis O Johnell A Oden, et al. 2005 Smoking and fracture risk: a meta-analysis Osteoporos Int 16 155 162 1:STN:280:DC%2BD2M%2FksVentA%3D%3D 10.1007/s00198-004-1640-3 15175845 (Pubitemid 40193202)
33. G Sachs Y Wen DR Scott 2009 Gastric infection by Helicobacter pylori Curr Gastroenterol Rep 11 455 461 10.1007/s11894-009-0070-y 19903421
34. N Figura L Gennari D Merlotti, et al. 2005 Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls Dig Dis Sci 50 847 852 1:STN:280:DC%2BD2M3msFSqtw%3D%3D 10.1007/s10620-005-2651-4 15906756 (Pubitemid 40684898)
35. TP van Staa F de Vries HG Leufkens 2006 Gastric acid-suppressive agents and risk of Clostridium difficile-associated disease JAMA 295 2599 10.1001/jama.295.22.2599-a 16772618 (Pubitemid 43882325)
36. A Cuomo M Romano A Rocco, et al. 2003 Reflux oesophagitis in adult celiac disease: beneficial effect of a gluten-free diet Gut 52 514 517 1:STN:280:DC%2BD3s7hvVagsA%3D%3D 10.1136/gut.52.4.514 12631661 (Pubitemid 36363403)
37. D Agardh S Björck CD Agardh, et al. 2009 Coeliac disease-specific tissue transglutaminase autoantibodies are associated with osteoporosis and related fractures in middle-aged women Scand J Gastroenterol 44 571 578 1:CAS:528:DC%2BD1MXltV2jt70%3D 10.1080/00365520902718929 19255929
38. C Jackson S Gaugris SS Sen, et al. 2007 The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis QJM 100 185 192 1:STN:280:DC%2BD2s3itlKhtQ%3D%3D 10.1093/qjmed/hcm005 17308327 (Pubitemid 47061686)
39. K Vuolteenaho T Moilanen E Moilanen 2008 Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process Basic Clin Pharmacol Toxicol 102 10 14 1:CAS:528:DC%2BD1cXhs1Cqt7Y%3D 17973900 (Pubitemid 350294081)